Post-market surveillance of GM foods: applicability and limitations of schemes used with pharmaceuticals and some non-GM novel foods

Author： Wal J.-M.   Hepburn P.A.   Lea L.J.   Crevel R.W.R.  

Publisher： Elsevier

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.38, Iss.1, 2003-08, pp. : 98-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

GM foods: is rational public debate possible?

By  

Clinical Medicine, Vol. 4, Iss. 2, 2004-03 ,pp. : 193-194

Royal College Of Physicians

Access to resources Recommend Favorite

Analysis of Tocopherols and Tocotrienols in Pharmaceuticals and Foods: A Critical Review

By  

Current Pharmaceutical Analysis, Vol. 11, Iss. 1, 2015-01 ,pp. : 66-78

Bentham Science Publishers

Access to resources Recommend Favorite

GM-CSF may be a novel strategy for Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Approaches to the Safety Assessmentof Novel Foods and Novel Gene Products

By Taylor Steve L.  

Comments® on Toxicology, Vol. 8, Iss. 3, 2002-05 ,pp. : 241-250

Taylor & Francis Ltd

Access to resources Recommend Favorite

Elevating the Terms of the GM Food Debate

By Flamm W.G.  

Regulatory Toxicology and Pharmacology, Vol. 33, Iss. 1, 2001-02 ,pp. : 1-1

Academic Press

Access to resources Recommend Favorite